Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Elicio Therapeutics, Inc. (ANGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
08/11/2023 8-K Quarterly results
Docs: "Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updates"
06/02/2023 8-K Completion of Acquisition or Disposition of Assets, Material Modifications to Rights of Security Holders, Changes in Registra...
Docs: "Certificate of Merger",
"Certificate of Amendment, to the Amended and Restated Certificate of Incorporation of Angion Biomedica Corp. to implement the Reverse Stock Split",
"Certificate of Amendment, to the Amended and Restated Certificate of Incorporation of Angion Biomedica Corp. to implement Officer Exculpation",
"Certificate of Amendment, to the Amended and Restated Certificate of Incorporation of Angion Biomedica Corp. to implement the name change",
"Suite 501 Boston, MA 02210",
"Form of Indemnification Agreement between the Company and each of its directions and officers",
"Information Rights Letter, by and between Clal Biotechnology Industries Ltd. and Elicio Therapeutics, Inc",
"Letter from Moss Adams LLP",
"NEWTON, Massachusetts, June 1, 2023 ––",
"Elicio Therapeutics Announces Completion of Merger with Angion Biomedica"
05/30/2023 8-K Other Events  Interactive Data
05/23/2023 8-K Other Events  Interactive Data
05/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Elicio Therapeutics to Present Interim Data from the Ongoing Phase 1study of Investigational Therapeutic Cancer Vaccine, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at ASCO",
"Elicio Corporate Twitter Post, May 1, 2023,"
04/27/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "G12D, G12V, G12R, G12C, G12S, G12A",
"Elicio Corporate Twitter Post, April 27, 2023,"
01/17/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Agreement and Plan of Merger and Reorganization, by and among Angion Biomedica Corp., Arkham Merger Sub, Inc. and Elicio Therapeutics, Inc",
"Note Purchase Agreement, by and between Elicio Therapeutics, Inc. and Angion Biomedica Corp., and Form of Promissory Note",
"Form of Angion Biomedica Corp. Stockholder Support Agreement",
"Form of Elicio Therapeutics, Inc. Stockholder Support Agreement",
"Form of Lock-Up Agreement",
"No Offer or Solicitation This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No public offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended."
12/21/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/15/2022 8-K Quarterly results
07/25/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
06/13/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
Docs: "Angion Provides Corporate Update and Reports First Quarter 2022 Financial Results"
03/30/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Angion Provides Corporate Update and Reports Full Year 2021 Financial Results"
03/04/2022 8-K Quarterly results
01/04/2022 8-K Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities  Interactive ...
11/12/2021 8-K Quarterly results
Docs: "Angion Provides Corporate Update and Reports Third Quarter 2021 Financial Results"
10/26/2021 8-K Results of Operations and Financial Condition  Interactive Data
08/30/2021 8-K Termination of a Material Definitive Agreement  Interactive Data
08/12/2021 8-K Quarterly results
Docs: "Angion Provides Corporate Update and Reports Second Quarter 2021 Financial Results"
06/29/2021 8-K Quarterly results
05/17/2021 8-K Quarterly results
03/30/2021 8-K Quarterly results
03/10/2021 8-K Quarterly results
02/09/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy